474 related articles for article (PubMed ID: 16959684)
1. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
[TBL] [Abstract][Full Text] [Related]
2. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
[TBL] [Abstract][Full Text] [Related]
3. Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexide.
Adiguzel C; Iqbal O; Hoppensteadt D; Jeske W; Cunanan J; Litinas E; He Zhu ; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009 Oct; 15(5):501-11. PubMed ID: 19703818
[TBL] [Abstract][Full Text] [Related]
4. The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity.
Fritzsche J; Alban S; Ludwig RJ; Rubant S; Boehncke WH; Schumacher G; Bendas G
Biochem Pharmacol; 2006 Aug; 72(4):474-85. PubMed ID: 16780802
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tissue factor-activated platelets by low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonist.
Ahmad S; Jeske WP; Ma Q; Walenga JM; Fareed J
Thromb Res; 2001 Apr; 102(2):143-51. PubMed ID: 11323025
[TBL] [Abstract][Full Text] [Related]
6. Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin.
Maugeri N; de Gaetano G; Barbanti M; Donati MB; Cerletti C
Haematologica; 2005 Jun; 90(6):833-9. PubMed ID: 15951297
[TBL] [Abstract][Full Text] [Related]
7. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications.
Haas S; Walenga JM; Jeske WP; Fareed J
Semin Thromb Hemost; 1999; 25 Suppl 1():67-75. PubMed ID: 10357155
[TBL] [Abstract][Full Text] [Related]
10. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
Zhao L; Bath PM; May J; Lösche W; Heptinstall S
Platelets; 2003; 14(7-8):473-80. PubMed ID: 14713516
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide.
Poggi A; Rossi C; Casella N; Bruno C; Sturiale L; Dossi C; Naggi A
Semin Thromb Hemost; 2002 Aug; 28(4):383-92. PubMed ID: 12244486
[TBL] [Abstract][Full Text] [Related]
12. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
Fox SC; May JA; Shah A; Neubert U; Heptinstall S
Platelets; 2009 Jun; 20(4):250-9. PubMed ID: 19440925
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 3 inhibition reduces platelet activation and monocyte tissue factor expression in knee arthroplasty patients.
Beppu S; Nakajima Y; Shibasaki M; Kageyama K; Mizobe T; Shime N; Matsuda N
Anesthesiology; 2009 Dec; 111(6):1227-37. PubMed ID: 19934866
[TBL] [Abstract][Full Text] [Related]
14. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.
Mousa SA; Ahmad S
Am J Hematol; 2007 Apr; 82(4):276-82. PubMed ID: 17039513
[TBL] [Abstract][Full Text] [Related]
15. Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
Platelets; 2006 Aug; 17(5):318-27. PubMed ID: 16928604
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs.
Camera M; Frigerio M; Toschi V; Brambilla M; Rossi F; Cottell DC; Maderna P; Parolari A; Bonzi R; De Vincenti O; Tremoli E
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1690-6. PubMed ID: 12855480
[TBL] [Abstract][Full Text] [Related]
17. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay.
Amirkhosravi A; Alexander M; May K; Francis DA; Warnes G; Biggerstaff J; Francis JL
Thromb Haemost; 1996 Jan; 75(1):87-95. PubMed ID: 8713785
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease?
Kälvegren H; Majeed M; Bengtsson T
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1677-83. PubMed ID: 12842841
[TBL] [Abstract][Full Text] [Related]
19. Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.
Messmore HL; Griffin B; Koza M; Seghatchian J; Fareed J; Coyne E
Semin Thromb Hemost; 1991; 17 Suppl 1():57-9. PubMed ID: 1712512
[TBL] [Abstract][Full Text] [Related]
20. Material-induced tissue factor expression but not CD11b upregulation depends on the presence of platelets.
Gorbet MB; Sefton MV
J Biomed Mater Res A; 2003 Dec; 67(3):792-800. PubMed ID: 14613227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]